Vimarsana
Biggest News Aggregation in the World

Page 9 - Three Quarters News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Three Quarters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Three Quarters Today - Breaking & Trending Today

Three quarters of UK tech workers are unhappy in their jobs, new report finds - Vimarsana News

Three quarters of UK tech workers are unhappy in their jobs, new report finds

Over three quarters (77 per cent) of tech talent in the UK are unhappy in their current jobs and actively seeking out new roles, according to a survey of over 1000...

Plaintree Systems Inc. Announces Third Quarter Fiscal 2023 Results - Vimarsana News

Plaintree Systems Inc. Announces Third Quarter Fiscal 2023 Results

ARNPRIOR, ON / ACCESSWIRE / February 23, 2023 / Plaintree Systems Inc. (CSE:NPT) ("Plaintree" or the "Company").Quarterly Statements for the first Three Quarters of Fiscal 2023 ending December 31, 2022.Plaintree

JB Pharma records revenue growth of 32 per cent to Rs 793 crores in Q3 FY23 - Vimarsana News

JB Pharma records revenue growth of 32 per cent to Rs 793 crores in Q3 FY23

Mumbai (Maharashtra) [India], February 11 (ANI/PNN): JB Pharma, one of the fastest-growing pharmaceutical companies in India, announced record revenue growth of 32 per cent to Rs 793 crore in Q3 FY23.

Business News | JB Pharma Records Revenue Growth of 32 Per Cent to Rs 793 Crores in Q3 FY23 - Vimarsana News

Business News | JB Pharma Records Revenue Growth of 32 Per Cent to Rs 793 Crores in Q3 FY23

Get latest articles and stories on Business at LatestLY. JB Pharma, one of the fastest-growing pharmaceutical companies in India, announced record revenue growth of 32 per cent to Rs 793 crore in Q3 FY23. Business News | JB Pharma Records Revenue Growth of 32 Per Cent to Rs 793 Crores in Q3 FY23.

JB Pharma Records Revenue Growth of 32% to Rs 793 Crores in Q3 FY23 - Vimarsana News

JB Pharma Records Revenue Growth of 32% to Rs 793 Crores in Q3 FY23

JB continues its growth journey delivering strong financial performance in the quarter: Nikhil Chopra, CEO and Wholetime Director, JB Pharma.

Source: india.com